Overview


According to FutureWise analysis the market for Next-generation Sequencing Data Analysis in 2023 is US$ 1.08 billion, and is expected to reach US$ 5.68 billion by 2031 at a CAGR of 23.00%.

Massively parallel sequencing (MPS) and next-generation sequencing (NGS) are words that describe a DNA sequencing technology that has greatly benefited biotechnology, medical diagnosis, forensic biology, biological systematics, and virology. The introduction of next-generation sequencing (NGS) has altered the way clinical research, basic science, and applied science are conducted. Next-generation sequencing technology, in compared to previous Sanger sequencing technology, allows for the sequencing of an entire human genome in a fraction of the time. Next-generation sequencing has affected the change from a traditional medicine paradigm of diagnosis to a precision medicine paradigm, allowing for the identification of biomarkers for early diagnosis and customised therapy. While Next Generation Sequencing is still a relatively young technology, it has swiftly become a cornerstone of molecular biology and genetics, with applications in personalised medicine, hereditary illnesses, and clinical diagnostics. Because it includes preparing the material for the future sequencing reaction, DNA pre-sequencing is one of the most important procedures in the total sequencing protocol. NGS is steadily being integrated into clinical laboratory analysis, testing, and illness diagnosis in the worldwide healthcare sector. NGS has been widely used in pharmacogenomics to speed up the drug discovery process. Increased genome mapping studies, increased uses of next generation sequencing, increased healthcare expenditure, and technological developments in sequencing platforms are all driving the industry forward.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Next-generation Sequencing Data Analysis Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Next-generation Sequencing Data Analysis Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Thermo Fisher Scientific, Inc.
  • QIAGEN
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • PierianDx
  • Precigen Bioinformatics Germany GmbH
  • Partek Incorporated
  • Eurofins Scientific
  • Pacific Biosciences of California, Inc.
  • DNASTAR, Inc.
  • Congenica Ltd.
  • Fabric Genomics, Inc.
  • Genuity Science
  • DNAnexus Inc.
  • SciGenom Labs Pvt. Ltd.
  • Golden Helix, Inc.
  • Verily Life Science

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Services
  • NGS Commercial Software
    • Platform OS/UI
    • Analytical Software
      • QC/Pre-processing Tools
      • Alignment Tools and Software
        • DNA Seq Alignment
        • RNA Seq Alignment
        • Protein Seq Alignment
    • Others

By Workflow

  • Primary
  • Secondary
    • Read Mapping
    • Variant Alignment and Variant Calling
  • Tertiary
    • Variant Annotation
    • Application Specific
      • Targeted Sequencing/ Gene Panel
      • Exome
      • RNA Seq
      • Whole Genome
      • Chip Seq
      • Others

By Mode

  • In-house
  • Outsourced

By Read Length

  • Short Read Sequencing
  • Long Read Sequencing
  • Very Long Read Sequencing

By End-use

  • Academic Research
  • Clinical Research
  • Hospitals and Clinics
  • Pharma Biotech Entities
  • Other Users

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Next-generation Sequencing Data Analysis Market By Product, By Workflow, By Mode, By Read Length, By End-use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Next-generation Sequencing Data Analysis Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Next-generation Sequencing Data Analysis Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Next-generation Sequencing Data Analysis Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Next-generation Sequencing Data Analysis Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Services
        2. NGS Commercial Software
         2.1. Platform OS/UI
         2.2. Analytical Software
          2.2.1. QC/Pre-processing Tools
          2.2.2. Alignment Tools and Software
           2.2.2.1. DNA Seq Alignment
           2.2.2.2. RNA Seq Alignment
           2.2.2.3. Protein Seq Alignment
         2.3. Others

  • 8.   Next-generation Sequencing Data Analysis Market, By Workflow Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Primary
        2. Secondary
         2.1. Read Mapping
         2.2. Variant Alignment and Variant Calling
        3. Tertiary
         3.1. Variant Annotation
         3.2. Application Specific
          3.2.1. Targeted Sequencing/ Gene Panel
          3.2.2. Exome
          3.2.3. RNA Seq
          3.2.4. Whole Genome
          3.2.5. Chip Seq
          3.2.6. Others

  • 9.   Next-generation Sequencing Data Analysis Market, By Mode Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. In-house
        2. Outsourced

  • 10.   Next-generation Sequencing Data Analysis Market, By Read Lengths Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Short Read Sequencing
        2. Long Read Sequencing
        3. Very Long Read Sequencing

  • 11.   Next-generation Sequencing Data Analysis Market, By End-use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Academic Research
        2. Clinical Research
        3. Hospitals and Clinics
        4. Pharma Biotech Entities
        5. Other Users

  • 12.   North America Next-generation Sequencing Data Analysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Next-generation Sequencing Data Analysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Next-generation Sequencing Data Analysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Next-generation Sequencing Data Analysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Next-generation Sequencing Data Analysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. QIAGEN
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Illumina, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. F. Hoffmann-La Roche Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Agilent Technologies, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bio-Rad Laboratories, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. PierianDx
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Precigen Bioinformatics Germany GmbH
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Partek Incorporated
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Eurofins Scientific
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Pacific Biosciences of California, Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. DNASTAR, Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Congenica Ltd.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Fabric Genomics, Inc.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Genuity Science
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. DNAnexus Inc.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. SciGenom Labs Pvt. Ltd.
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Golden Helix, Inc.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Verily Life Science
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients